Cadrenal Therapeutics, Inc. Common StockCVKDNASDAQ
LOADING
|||
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-10.65M
↓ 25% below average
Average (2y)
$-8.53M
Historical baseline
Range
High:$-6.61M
Low:$-10.65M
CAGR
+27.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-10.65M | -27.7% |
| 2023 | $-8.34M | -26.2% |
| 2022 | $-6.61M | - |